Learn About Pancreatic Cancer Screening and Tests
Understanding Pancreatic Cancer and Why Screening Matters
Pancreatic cancer is one of the most serious types of cancer, with a five-year survival rate of about 12 percent according to the National Cancer Institute. This low survival rate occurs largely because pancreatic cancer is often found at advanced stages, when the disease has already spread to other parts of the body. Understanding the basic facts about pancreatic cancer can help you make informed decisions about screening and monitoring your health.
Open a Chase Bank Account Online Guide →
The pancreas is a gland located behind the stomach that produces digestive juices and insulin. When cancer develops in the pancreas, it can interfere with both digestion and blood sugar control. There are different types of pancreatic cancer. The most common form is called ductal adenocarcinoma, which accounts for about 85 percent of all pancreatic cancer cases. This type starts in the cells that line the ducts that carry digestive juices.
The reason screening and early detection matter is straightforward: patients diagnosed with pancreatic cancer at stage 1 have a significantly better outcome than those diagnosed at later stages. When caught early, before the cancer has spread, surgery to remove the tumor offers the best chance for survival. However, the pancreas sits deep inside the abdomen, making tumors difficult to detect through physical examination alone.
Risk factors for pancreatic cancer include smoking, obesity, diabetes, chronic pancreatitis, and a family history of the disease. People with certain inherited genetic mutations, such as BRCA2 or Lynch syndrome, face higher risk. Additionally, men are slightly more likely to develop pancreatic cancer than women, and the disease becomes more common with age.
Practical takeaway: If you have multiple risk factors for pancreatic cancer or a family history of the disease, discussing screening options with your doctor provides information that may help guide your healthcare decisions.
Who Should Consider Pancreatic Cancer Screening
Pancreatic cancer screening is not recommended for the general population without risk factors. This is because screening tests can be invasive, expensive, and may produce false results that lead to unnecessary procedures. However, certain groups of people may benefit from discussing screening with their healthcare provider. Understanding whether you fall into a higher-risk category is an important first step.
How to Pay Your TJ Maxx Bill Online →
People with a strong family history of pancreatic cancer should consider talking with their doctor about screening. This includes individuals who have two or more close relatives (parent, sibling, or child) who were diagnosed with pancreatic cancer. Families with hereditary cancer syndromes, such as Lynch syndrome, hereditary breast and ovarian cancer syndrome (associated with BRCA mutations), or familial adenomatous polyposis, also face higher pancreatic cancer risk and may benefit from medical evaluation.
Individuals with chronic pancreatitis—long-term inflammation of the pancreas—have a substantially increased risk of developing pancreatic cancer. People with this condition should discuss monitoring options with their healthcare team. Similarly, patients with new-onset diabetes, particularly those over age 50, may warrant further evaluation, as diabetes can sometimes be an early sign of pancreatic cancer.
People who carry known genetic mutations associated with increased cancer risk should speak with their doctors about screening. Genetic counselors and oncologists can review family history and test results to determine whether screening might be appropriate. It is important to note that having a risk factor does not mean someone will develop pancreatic cancer; rather, it means the risk is higher than average.
Current smokers and people with significant obesity are at higher risk, but screening recommendations for these groups are still evolving. Some medical centers specializing in pancreatic cancer offer screening programs for high-risk individuals, though these programs are not yet standard practice everywhere.
Practical takeaway: Write down your family health history, including any relatives diagnosed with pancreatic cancer, and share this information with your doctor to determine whether screening might be something to discuss further.
Common Screening and Diagnostic Tests for Pancreatic Cancer
Several tests can be used to screen for pancreatic cancer or to investigate symptoms that suggest pancreatic disease. Understanding what these tests involve and how they work can help you prepare for medical appointments and conversations with your healthcare team.
Endoscopic ultrasound (EUS) is a procedure often used to examine the pancreas in detail. During EUS, a doctor passes a thin, flexible tube (endoscope) down the throat and into the small intestine. The endoscope has an ultrasound probe at its tip that produces detailed images of the pancreas and surrounding tissues. This procedure can detect small tumors and allows the doctor to take a tissue sample (biopsy) if an abnormality is found. EUS is considered one of the most sensitive tests for finding pancreatic cancer in high-risk individuals, but it is invasive and requires sedation.
Magnetic resonance imaging (MRI) and magnetic resonance cholangiopancreatography (MRCP) use magnetic fields and radio waves to create detailed pictures of the pancreas and bile ducts. These tests are non-invasive and do not use radiation. MRCP is particularly useful for examining the pancreatic ducts. MRI can identify tumors and help doctors understand whether cancer has spread to nearby structures.
Computed tomography (CT) scanning uses X-rays to create cross-sectional images of the abdomen. A CT scan can show the size and location of pancreatic tumors and whether the cancer has spread to lymph nodes or other organs. Newer CT technology, such as multislice CT, provides highly detailed images. This test is fast and non-invasive, though it does involve radiation exposure.
Blood tests may measure tumor markers such as carcinoembryonic antigen (CEA) and cancer antigen 19-9 (CA 19-9). Elevated levels of CA 19-9 can suggest pancreatic cancer, though this marker can also be elevated in benign pancreatic conditions. Blood tests alone cannot diagnose pancreatic cancer but may be used alongside imaging tests to monitor disease progression or treatment response.
Positron emission tomography (PET) scans use a radioactive substance to highlight areas of high activity in the body, often showing where cancer is present. PET scans may be combined with CT scans (PET-CT) to provide more complete information about whether cancer has spread.
Practical takeaway: When your doctor recommends a test, ask what it involves, why it is being performed, and how the results will be used to guide your care. This helps you understand the purpose of each test and what to expect.
What Happens During and After Pancreatic Cancer Screening
Knowing what to expect during a screening procedure can reduce anxiety and help you prepare mentally and physically. Different tests have different requirements and timelines.
How to Turn Off Comments on TikTok Videos →
If you are undergoing endoscopic ultrasound, you will typically be asked to fast (avoid food and drink) for 6-8 hours before the procedure. You will receive sedation to keep you comfortable, and the procedure usually takes 20-30 minutes. After EUS, you will need someone to drive you home, as sedation requires time to wear off. You may experience mild throat soreness afterward. Your doctor will contact you with results, typically within a few days.
For CT and MRI scans, preparation depends on the specific type of scan and whether contrast dye is being used. If contrast is used, you may be asked to avoid eating for several hours before the scan. The scanning itself is quick—usually lasting 10-30 minutes—and you can return to normal activities immediately afterward. Results are typically available within one to two weeks.
Blood tests require only a brief appointment at a laboratory. A technician draws a small sample of blood, and results usually come back within one to three business days. There is no recovery time needed.
After screening tests, your doctor will review the results with you and explain what was found. If no abnormalities were detected, your doctor may recommend continued monitoring or regular follow-up screening, depending on your risk factors. If an abnormality is found, your doctor may recommend additional tests to confirm a diagnosis or may refer you to a specialist such as a gastroenterologist or oncologist.
If pancreatic cancer is diagnosed, staging tests will determine how far the cancer has spread. This information guides treatment decisions. Staging involves additional imaging and possibly blood tests. Your doctor will discuss treatment options, which may include surgery, chemotherapy, radiation therapy, or combinations of these approaches.
Practical takeaway: After any screening test, write
This guide is general information, not professional advice. Offices and providers set their own rules, so check the details with the one you’re seeing. See our Editorial Policy.